FOXO3 and esophageal squamous cell carcinoma: In conclusion, the circ-Foxo3/miR-23a/PTEN signaling pathway highlights some promising therapeutic targets, and the structure of circ-Foxo3 could make circ-Foxo3 a reliable biomarker for ESCC patients.